【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
• Pipeline portfolio: Global diabetes drugs market
• Pipeline portfolio: Global hyperphosphatemia drugs market
• Pipeline portfolio: Global anti-obesity drugs market
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by type of disease
• Diabetes
• Obesity
• Hypercholesterolemia
• Lysosomal storage diseases
PART 08: Global diabetes drugs market
• Market overview
• Global type 1 diabetes market
• Global type 2 diabetes drugs market
• Vendors in global diabetes drugs market
PART 09: Global hypercholesterolemia drugs market
• Market overview
• Vendors in global hypercholesterolemia drugs market
PART 10: Global lysosomal storage diseases market
• Market overview
• Vendors in global lysosomal storage disorders drugs market
PART 11: Global anti-obesity drugs market
• Market overview
• Vendors in global anti-obesity drugs market
PART 12: Geographical segmentation
• Global metabolic disorders therapeutics market by geography 2015-2020
• Metabolic disorders therapeutics market in Americas
• Metabolic disorders therapeutics market in EMEA
• Metabolic disorders therapeutics market in APAC
PART 13: Market drivers
• Patient assistance programs
• Special regulatory designations for rare diseases
• Increase in academia-industry collaborations for drug development
PART 14: Impact of drivers
PART 15: Market challenges
• Low compliance and adherence rates
• High cost of therapies
• Complex storage conditions and distribution policies for insulin
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Focus on oral insulin therapies
• Strong and diversified pipeline portfolio
• Strategic collaborations and acquisitions
PART 18: Vendor landscape
• Competitive scenario
• Other prominent vendors
•
PART 19: Key vendor analysis
• Novo Nordisk
• Sanof
• Merck
• AstraZeneca
• Eli Lilly
PART 20: Appendix
• List of abbreviations
PART 21: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria and customer segments for metabolic disorder drugsKey buying criteria for metabolic disorders drugs 2015
Exhibit 03: Impact of key customer segments on market 2015
Exhibit 04: Global metabolic disorders therapeutic market snapshot: Developed and emerging markets 2015
Exhibit 05: Global metabolic disorders therapeutics market 2015-2020 ($ billions)
Exhibit 06: Opportunity analysis: Global metabolic disorders therapeutics market
Exhibit 07: Global metabolic disorders therapeutics market: Growth cycle analysis
Exhibit 08: Five forces analysis
Exhibit 09: Global metabolic disorders therapeutics market by type of disease
Exhibit 10: Global metabolic disorders therapeutics market by type (2015-2020)
Exhibit 11: Global metabolic disorders therapeutics market n growth lifecycle analysis
Exhibit 12: Top selling diabetes drugs based on sales 2015 ($ billions)
Exhibit 13: Market share of global diabetes drugs in global pharmaceutical market 2015
Exhibit 14: Global diabetes drugs market 2015-2020 ($ billions)
Exhibit 15: Global type 1 diabetes market 2015-2020 ($ billions)
Exhibit 16: Global type 2 diabetes drugs market 2015-2020 ($ billions)
Exhibit 17: Market share analysis of vendors in global diabetes drugs market
Exhibit 18: Revenues from the sales of top five products in global diabetes drugs market 2013-2015 ($ billions)
Exhibit 19: Revenues from the sales of top five products in hypercholesterolemia drugs market 2013-2015 ($ billions)
Exhibit 20: Market dynamics of hypercholesterolemia drugs
Exhibit 21: Percentage share of hypercholesterolemia drugs by drug class 2015
Exhibit 22: Global hypercholesterolemia drugs market 2015-2020 ($ billions)
Exhibit 23: Market share analysis of global hypercholesterolemia drugs market 2015
Exhibit 24: Products offered by major vendors in global hypercholesterolemia drugs market
Exhibit 25: Global lysosomal storage diseases drugs market 2015-2020 ($ billions)
Exhibit 26: Key events in treatment of lysosomal storage diseases
Exhibit 27: Products offered by major vendors in global lysosomal storage disorders drugs market
Exhibit 28: Global anti-obesity drugs market 2015-2020 ($ millions)
Exhibit 29: Products offered by major vendors in global anti-obesity drugs market
Exhibit 30: Global metabolic disorders therapeutics market by geography 2015-2020
Exhibit 31: Global metabolic disorder therapeutics market by geography 2015 and 2020
Exhibit 32: Global metabolic disorder therapeutics market by geography 2015-2020 ($ billions)
Exhibit 33: Global share of metabolic disorder therapeutics market by geography 2015
Exhibit 34: Global share of various metabolic disorder therapeutics market by geography based on disease type 2015
Exhibit 35: Global metabolic disorders therapeutics market by region: Market growth lifecycle analysis 2015
Exhibit 36: Metabolic disorder therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 37: Prevalence of obesity in various countries in Europe 2025
Exhibit 38: Metabolic disorders therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 39: Metabolic disorder therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 40: Prevalence of diabetes in selected countries in APAC 2007 and 2025
Exhibit 41: Few metabolic disorder drugs with patient assistance programs
Exhibit 42: Impact of drivers
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Oral insulin pipeline portfolio
Exhibit 45: Some investigational molecules for metabolic disorders and their mechanisms
Exhibit 46: Key vendors ranking 2015
Exhibit 47: Geographical presence of key vendors
Exhibit 48: Competitive scenario of global metabolic disorders therapeutics market vendors 2015-2020
Exhibit 49: Novo Nordisk: Profile
Exhibit 50: Novo Nordisk: Strength analysis
Exhibit 51: Novo Nordisk: Growth strategy matrix
Exhibit 52: Novo Nordisk: Growth opportunity assessment
Exhibit 53: Novo Nordisk: Business segmentation by revenue 2015
Exhibit 54: Novo Nordisk: Key products in diabetes and obesity care
Exhibit 55: Novo Nordisk: YoY growth and revenue generated from net product sales of human insulins 2012-2015 ($ billions)
Exhibit 56: Novo Nordisk: YoY growth and revenue generated from net product sales of Levemir 2012-2015 ($ billions)
Exhibit 57: Novo Nordisk: YoY growth and revenue of NovoRapid/ NovoLog 2012-2015 ($ billions)
Exhibit 58: Novo Nordisk: YoY growth and revenue of NovoMix/NovoLog Mix 2012-2015 ($ billions)
Exhibit 59: Novo Nordisk: Revenue generated from net product sales of new-generation insulins 2013-2015 ($ millions)
Exhibit 60: Novo Nordisk: YoY growth and revenue of Victoza 2012-2015 ($ billions)
Exhibit 61: Novo Nordisk: YoY growth and revenue of Novonorm, Prandin, and Prandimet 2012-2014 ($ billions)
Exhibit 62: Sanofi: Business segmentation by revenue 2015
Exhibit 63: Sanofi: Profile
Exhibit 64: Sanofi: Strength analysis
Exhibit 65: Sanofi growth strategy matrix
Exhibit 66: Sanofi: Growth opportunity assessment
Exhibit 67: Key product offerings in diabetes market ($ billions)
Exhibit 68: Sanofi: YoY revenue and growth rate of Lantus 2012-2015 ($ billions)
Exhibit 69: Sanofi: YoY revenue and growth rate of Amaryl 2012-2015 ($ billions)
Exhibit 70: Sanofi: YoY revenue and growth rate of Apidra 2012-2015 ($ billions)
Exhibit 71: Sanofi: YoY revenue and growth rate of Insuman 2012-2015 ($ billions)
Exhibit 72: Sanofi: YoY revenue and growth rate of Lyxumia 2013-2015 ($ millions)
Exhibit 73: Sanofi: Revenues of lysosomal storage diseases drugs of Genzyme, 2015
Exhibit 74: Merck: Strength profile
Exhibit 75: Merck: Strength analysis
Exhibit 76: Merck: Growth strategy matrix
Exhibit 77: Merck: Opportunity assessment
Exhibit 78: Top selling diabetes drugs in 2015
Exhibit 79: Merck: Diabetes segmentation by revenue 2015
Exhibit 80: Merck: YoY growth and revenue of Janumet 2012-2015 ($ billions)
Exhibit 81: Merck: YoY growth and revenue of Januvia 2012-2015 ($ billions)
Exhibit 82: Merck: YoY revenue and growth rate of Zetia 2013-2015 ($ billions)
Exhibit 83: Merck: YoY revenue and growth rate of Vytorin 2013-2015 ($ billions)
Exhibit 84: Merck: YoY revenue and growth rate of Zocor 2013-2015 ($ millions)
Exhibit 85: AstraZeneca: Profile
Exhibit 86: AstraZeneca: Strength analysis
Exhibit 87: AstraZeneca: Growth strategy matrix
Exhibit 88: AstraZeneca: Opportunity assessment
Exhibit 89: Top selling diabetes drugs in 2015 ($ billions)
Exhibit 90: AstraZeneca: Byetta YoY growth and revenues 2012-2015 ($ billions)
Exhibit 91: Astrazeneca: Byetta YoY growth rate and revenues in the US ($ billions)
Exhibit 92: AstraZeneca: Bydureon YoY revenues and growth rate 2012-2015 ($ billions)
Exhibit 93: AstraZeneca: Onglyza YoY revenue and growth rate 2012-2015 ($ billions)
Exhibit 94: AstraZeneca: YoY revenue and growth rate of Crestor 2013-2015 ($ billions)
Exhibit 95: AstraZeneca: Geographical segmentation of Crestor 2015 by revenue
Exhibit 96: Eli Lilly: Profile
Exhibit 97: Eli Lilly: Strength analysis
Exhibit 98: Eli Lilly growth strategy matrix
Exhibit 99: Eli Lilly: Opportunity assessment
Exhibit 100: Top selling diabetic drugs 2015 ($ billions)
Exhibit 101: Eli Lilly: YoY revenue and growth rate of Humalog 2012-2015 ($ billions)
Exhibit 102: Eli Lilly: YoY revenue and growth rate of Humulin 2012-2015 ($ billions)
Exhibit 103: Eli Lilly: YoY revenue and growth rate of Tradjenta 2012-2015 ($ billions)
Exhibit 104: Eli Lilly: YoY revenue of Trylicity 2014-2015 ($ millions)
【レポート販売概要】
■ タイトル:代謝疾患治療薬の世界市場:高血圧、肥満、高コレステロール血症、ライソゾーム病■ 英文:Global Metabolic Disorders Therapeutics Market 2016-2020
■ 発行日:2016年9月27日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10218
■ 調査対象地域:グローバル
- バックオフィス向けシステム統合ソリューションの世界市場About the Back Office System Integration MarketSystem integration solutions are used to integrate multiple systems, applications, and components in the information, communications, and technology (ICT) infrastructure of organizations. System integration solutions can be applied on the IT architecture of front office and back office to connect sub-systems and devices to exchange information within …
- ニューラルネットワークソフトウェアの世界市場予測(~2021):種類別(データマイニング&データアーカイブ、分析ソフトウェア、最適化ソフトウェア、可視化ソフトウェア)、産業別、地域別“Increasing demand for predicting solutions and analytical tools is expected to drive the neural network software market”MarketsandMarkets forecasts the global neural network software market to expand from USD 7.17 billion in 2016 to USD 22.55 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 33.2%. The market is escalating rapidly owing to rising digitization trend and the surplus amoun …
- 機械安全用製品の世界市場:プレゼンスセンシング・セーフティセンサー、PLCS、セーフティ・コントローラ/モジュール/リレー、緊急停止制御、安全インターロックスイッチThe machine safety market is expected to reach USD 4.98 Billion by 2020 at a CAGR of 7.5% between 2015 and 2020. These safety systems are used in various applications such as assembling materials, material handling, metal working, packaging, robotics, and welding among others. The market for machine safety systems is likely to witness a steady growth in the coming years. Factors which are driving …
- 非住宅用加湿器の世界市場2017-2021:断熱式加湿器、恒温加湿器About Non-Residential Humidifier Non-residential humidifiers are used to maintain the suitable moisture content of environmental air in manufacturing facilities, office buildings, clean rooms, data centers, laboratories, and hospitals. The need for humidification of the environment in commercial and industrial facilities is driven by manufacturing process stabilization, the need for a comfortable …
- カリ肥料の世界市場(~2019)The expansion of the global potassic fertilizer industry is forecast to reach 2.9% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 1.7%. Currently, potassium chloride accounts for 92.5% of the global demand while the remaining market share is divided between potassium sulphate (4.5%) and other potassic fertilizers (3.0%). China, Germany, India, …
- スマートコーヒーメーカーの世界市場2017-2021About Smart Coffee MakerA coffee maker is a countertop appliance that brews hot coffee. Smart coffee makers are the part of automatic coffee brewing machines. Smart coffee makers are enabled with Wi-Fi and Bluetooth and can be operated by using an app on a smartphone. These smart coffee makers can be used from distant locations and offer the benefit of remotely controlling the device through smart …
- 赤外線イメージングの世界市場:赤外線レンズシステム、赤外線センサー、赤外線検知器The global infrared imaging market is expected to grow from USD 6.43 Billion in 2015 to USD 11.36 Billion by 2022, at a CAGR of 8.32% between 2016 and 2022. The market is expected to grow substantially due to factors such as surge in demand for infrared imaging in nearly all commercial applications, advantages of LWIR cameras with uncooled technology, and the decreasing cost of IR detectors. IR le …
- 世界の医療用セラミック市場動向(2012-2016)TechNavio’s analysts forecast the Global Medical Ceramics market to grow at a CAGR of 4.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing demand for cosmetic dentistry. The Global Medical Ceramics market has also been witnessing its application in hip replacement implants. However, threat of brand loyalty to small companies could pose a …
- クロマトグラフィー用試薬の世界市場:HPLC溶剤、GC溶剤、バッファー、シリル化試薬、アシル化試薬、イオン対試薬Chromatography technique helps separating and analyzing mixtures of chemicals in different application areas such as life sciences; food & beverage testing; environmental testing; forensics; and industries such as cosmetics, chemicals, oil, and petroleum, among others. The type of chromatography technique used depends on the sample to be analyzed or compounds to be separated. The global chromatogr …
- 世界のファイナンス及び会計BPO市場動向(2012-2016)TechNavio's analysts forecast the Global Finance and Accounting BPO market to grow at a CAGR of 8.04 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing focus of enterprises on core competencies. The Global Finance and Accounting BPO market has also been witnessing the increasing focus of vendors in the mid-market. However, the lack of dom …
- 湿度センサーの世界市場2018-2022About Humidity Sensor A humidity sensor measures and reports relative humidity in the atmosphere. It measures both air temperature and moisture content in the surrounding atmosphere. Technavio’s analysts forecast the global humidity sensor market to grow at a CAGR of 12.07% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the gl …
- 農業用ハーベスタの世界市場:コンバインハーベスタ、フォーレージハーベスタAbout the Agricultural Harvester Market The market is driven by a number of factors, with the shrinking labor force being one of the most important triggers. As a result of the shrinking labor force, farmers have to bear the significant business loss, especially at the time of harvesting and are investing in harvesters, which allow for highly efficient farming. An increase in government support an …
- 世界のタッチスクリーン市場(市場予測、機会、トレンド2013-2016)With the growth of tablet PCs and smartphones the global industry for touchscreens has witnessed substantial growth. A touchscreen detects and locates and touch over a display area. The touchscreen is sensitive to the touch of human fingers or even passive objects such as a stylus. Touchscreen displays are being used widely in computers, iPads, gaming consoles, PDAs, tablets, smartphones, public k …
- 建設用重ダンプトラックの世界市場2017-2021ABSTRACTAbout Construction Dumper A construction dumper is defined as the medium used to transport loose materials such as sand, gravel, aggregates, and others for construction purposes. A construction dumper has an open bed box at the rear end of the dump truck; it has a hydraulic piston, which lifts the hauler or trailer to dump the required material onto the ground. A construction dumper is def …
- 脂肪肝:治療薬の治験動向(2014年下半期)Fatty Liver Disease Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, H2, 2014" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recru …